Commercially available liquid biopsy data may be misleading

Posted on December 16, 2017 by Sitemaster

A newly published research letter in JAMA Oncology is entitled “Patient-paired sample congruence between 2 commercial liquid biopsy tests”. The two tests are both said — by the companies that market them — to have high clinical sensitivity and specificity in the identification of specific genetic markers associated with high-risk forms of prostate cancer. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , | 2 Comments »

FDA checking on reports of “problems” with da Vinci robot

Posted on March 1, 2013 by Sitemaster

According to an on-line report in the Financial Times published late last night, “The FDA has received an increase in reports of problems associated with [Intuitive’s  da Vinci robotic surgical technology] and said it is trying to weigh the risks and benefits of using robotic surgery rather than conventional surgery.” … READ MORE …

Filed under: Uncategorized | Tagged: , , , | 2 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives